Raadi | Blue Cross MN

Soo bandhiga 2311 - 2320 ee natiijooyinka 4128

Bixiye

Pre-Authorization (PA) Request Form (PDF)

Wax badan akhri

Bixiye

Formulary Exception and Tier Authorization - Only SecureBlue (HMO) (PDF)

Wax badan akhri

Bixiye

Step Therapy Authorization - Only for SecureBlue (HMO) (PDF)

Wax badan akhri

Bixiye

QP95-21 Update for New to Market Medical Drugs: triamcinolone acetonide injectable suspension (Xipere) and vutrisiran

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021

Bixiye

QP96-21 Processing Change for HCPCS Code A9279

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021

Bixiye

QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021

Bixiye

QP98-21 Commercial Pharmacy Benefit Exclusion for Nulojix® and Susvimo™

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021

Bixiye

QP99-21 Blue Cross and Blue Shield of Minnesota Collaboration with VillageHealth

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021

Bixiye

QP100-21 Checks to be Sent for Unpaid Prompt Pay Penalties

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021

Bixiye

QP101-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective February 1, 2022

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2021